Drug Profile
Celecoxib intravenous - Teva
Alternative Names: AI-525; CEP-33222Latest Information Update: 11 Nov 2021
Price :
$50
*
At a glance
- Originator Acusphere
- Developer Teva Pharmaceutical Industries
- Class Antimigraines; Antineoplastics; Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrazoles; Small molecules; Sulfonamides
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Postoperative pain